Territory Stories

Ministerial Statement Kava Licensing Issues



Ministerial Statement Kava Licensing Issues

Other title

Tabled paper 2012


Tabled Papers for 8th Assembly 1997 - 2001; Tabled Papers; ParliamentNT




Tabled by Timothy Baldwin


Made available by the Legislative Assembly of the Northern Territory under Standing Order 240. Where copyright subsists with a third party it remains with the original owner and permission may be required to reuse the material.




Tabled papers

File type




Copyright owner

See publication



Parent handle


Citation address


Page content

This is probably best summed up in a letter to the 4 August, 1997, edition of the Medical Journal of Australia by doctors Paul Spillane, Dale Fisher and Bart Currie: Let me quote: Abnormal liver function tests, malnutrition and kava dermopathy... are adverse effects of heavy kava use that have been commonly seen in Arnhem Land communities. Anecdotal associations with heavy kava use raised by local health care workers include increased rates of infectious diseases(beyond the already high rates), especially the potentially fatal melioidosis; malnutrition in dependants of kava drinkers; ischaemic cardiac events, including myocardial infarction and sudden death; and grand mal seizures attributed to both acute toxicity and withdrawal Or we can turn to the suggested conclusions and recommendations of the draft report, and again let me quote: The evidence contained in this report is a clear indication that the present situation regarding kava in Arnhem Land is unsatisfactory in many ways, and should not be allowed to continue.

Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.